-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Immunocore Holdings, Maintains $100 Price Target

Benzinga·06/02/2025 14:45:23
Listen to the news
HC Wainwright & Co. analyst Patrick Trucchio reiterates Immunocore Holdings (NASDAQ:IMCR) with a Buy and maintains $100 price target.